ARTICLE | Clinical News

Replagal agalsidase alfa: Phase II results; approved in Europe; under FDA review

October 1, 2001 7:00 AM UTC

TKTX published in Circulation additional results from a previously reported U.S placebo-controlled Phase II study of 26 patients with Fabry disease showing that patients given Replagal had increased c...